zabofloxacin

Small moleculeexperimental

Zabofloxacin (DW-224a) is an investigational fluoroquinolone antibiotic for multidrug-resistant infections due to Gram-positive bacteria. It also has activity against Neisseria gonorrhoeae including strains that are resistant to other quinolone antibiotics. — Wikipedia

Clinical trial activity

4 trials · 29 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
2
Phase 3
1
Phase 4
0

Earliest trial started Mar 1, 2010 (NCT01081964)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2012

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CO/N=C1\CN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC12CNC2
Mol. weight
401.4 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dw224a
  • dw-224a
  • zabofloxacin
  • zabofloxacin
  • zabofloxacin
  • zabofloxacin
  • zabofloxacin
  • zabofloxacin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02212795Phase 1May 1, 2014Chonbuk National University, DongWha Pharmaceutical Company
NCT01658020Phase 3Aug 1, 2012Ajou University, Catholic University of Korea, Cha Medical University, Chonbuk National University, Chonnam National University, Chosun University, Chungbuk National University, Chungnam National University, Dongguk University, DongWha Pharmaceutical Company, Ewha Womans University, Gachon University, Gyeongsang University, Hallym University, Hanyang University, Inje University, KangWon National University, Keimyung University, Konkuk University, Konyang University, Korea University, Kyung Hee University, Sungkyunkwan University, University of Ulsan, Wonju Christian Hospital, Yeungnam University, Yonsei University
NCT01341249Phase 1Apr 1, 2011DongWha Pharmaceutical Company, Seoul National University
NCT01081964Phase 2Mar 1, 2010IASO Pharma Inc.
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (29)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
DongWha Pharmaceutical CompanyFor profit3222011
Chonbuk National UniversityAcademic/Hospital2022012
Ajou UniversityAcademic/Hospital1012012
Catholic University of KoreaAcademic/Hospital1012012
Cha Medical UniversityAcademic/Hospital1012012
Chonnam National UniversityAcademic/Hospital1012012
Chosun UniversityAcademic/Hospital1012012
Chungbuk National UniversityAcademic/Hospital1012012
Chungnam National UniversityAcademic/Hospital1012012
Dongguk UniversityAcademic/Hospital1012012
Ewha Womans UniversityAcademic/Hospital1012012
Gachon UniversityAcademic/Hospital1012012
Gyeongsang UniversityAcademic/Hospital1012012
Hallym UniversityAcademic/Hospital1012012
Hanyang UniversityAcademic/Hospital1012012
IASO Pharma Inc.For profit1112010
Inje UniversityAcademic/Hospital1012012
KangWon National UniversityAcademic/Hospital1012012
Keimyung UniversityAcademic/Hospital1012012
Konkuk UniversityAcademic/Hospital1012012
29 organizations
Page 1 / 2